Changes in Cross-Sectional Area of Spinal Canal and Vertebral Body Under 2 Years of Teriparatide Treatment: Results from the EUROFORS Study

Por Schnell, R., Graeff, C., Krebs, A., Oertel, H., Glüer, C.-C.
Publicado em 2010

Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice: A consensus report of a European Society for Clinical and Economic Asp...

Por Harvey, N.C., Glüer, C.C., Binkley, N., McCloskey, E.V., Brandi, M-L., Cooper, C., Kendler, D., Lamy, O., Laslop, A., Camargos, B.M., Reginster, J-Y., Rizzoli, R., Kanis, J.A.
Publicado no Bone (2015)

Cancer-associated bone disease

Por Rizzoli, R., Body, J.-J., Brandi, M.-L., Cannata-Andia, J., Chappard, D., El Maghraoui, A., Glüer, C.C., Kendler, D., Napoli, N., Papaioannou, A., Pierroz, D.D., Rahme, M., Van Poznak, C.H., de Villiers, T.J., El Hajj Fuleihan, G.
Publicado no Osteoporos Int (2013)

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

Por Farahmand, P., Marin, F., Hawkins, F., Möricke, R., Ringe, J. D., Glüer, C.-C., Papaioannou, N., Minisola, S., Martínez, G., Nolla, J. M., Niedhart, C., Guañabens, N., Nuti, R., Martín-Mola, E., Thomasius, F., Peña, J., Graeff, C., Kapetanos, G., Petto, H., Gentzel, A., Reisinger, A., Zysset, P. K.
Publicado em 2013